MA09.05 Nivolumab Alone or with Ipilimumab in Recurrent Small Cell Lung Cancer (SCLC): 2-Year Survival and Updated Analyses from the Checkmate 032 Trial

View/Open

Supporting information (63.31Kb)

Date

2017-01

ICR Author

Marsden,

Author

Hellmann, M

Antonia, S

Ponce, S

Ott, P

Calvo, E

Taylor, M

Ready, N

Hann, C

De Braud, F

Eder, JP

Jäger, D

Ascierto, P

Horn, L

Amin, A

Evans, J

Moreno, V

Atmaca, A

Pillai, R

Bhosle, J

Bono, P

Reguart, N

Schneider, J

Brossart, P

Diamond, J

Sharma, P

Lassen, U

Lin, C-S

Tschaika, M

Selvaggi, G

Spigel, D

Show allShow less

Type

Journal Article

Metadata

Show full item record

URI

https://repository.icr.ac.uk/handle/internal/1442

DOI

https://doi.org/10.1016/j.jtho.2016.11.446

Collections

• Other ICR Research

Language

eng

License start date

2017-01

Citation

Journal of Thoracic Oncology, 2017, 12 (1), pp. S393 - S394

Publisher

Elsevier BV